カテゴリ： MarketLine, アメリカ, 企業調査

JPMorgan Chase & Co.：企業の戦略・SWOT・財務情報

◆英語タイトル：JPMorgan Chase & Co. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15447
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：53
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

JPMorgan Chase & Co. – Strategy, SWOT and Corporate Finance Report
Summary

JPMorgan Chase & Co. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

JPMorgan Chase & Co. (JPMC or ‘the bank’) is one of the leading global financial services firms and one of the largest banking institutions in the US. The company offers services such as cash management, payment solutions, residential mortgages, home equity loans, investment products and services, and financing to real estate investors and owners. The bank also offers fund custody, liquidity and investment services, securities lending, merchant services and auto, home lending, trade solutions among others. JPMC provides these services to consumers, small businesses, corporate, institutional, and government clients. The company operates in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in New York City, New York, the US.

Scope

- Detailed information on JPMorgan Chase & Co. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting JPMorgan Chase & Co. in the form of a SWOT analysis
- An in-depth view of the business model of JPMorgan Chase & Co. including a breakdown and examination of key business segments
- Intelligence on JPMorgan Chase & Co.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about JPMorgan Chase & Co., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of JPMorgan Chase & Co. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess JPMorgan Chase & Co. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on JPMorgan Chase & Co.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
JPMorgan Chase & Co.: Company Overview
JPMorgan Chase & Co.: Overview and Key Facts
JPMorgan Chase & Co.: Overview
JPMorgan Chase & Co.: Key Facts
JPMorgan Chase & Co.: Key Employees
JPMorgan Chase & Co.: Key Employee Biographies
JPMorgan Chase & Co.: Major Products and Services
JPMorgan Chase & Co.: Company History
JPMorgan Chase & Co.: Management Statement
JPMorgan Chase & Co.: Locations and Subsidiaries
JPMorgan Chase & Co.: Key Competitors
JPMorgan Chase & Co.: Company Analysis
JPMorgan Chase & Co.: Business Description
JPMorgan Chase & Co.: SWOT Analysis
JPMorgan Chase & Co.: SWOT Overview
JPMorgan Chase & Co.: Strengths
JPMorgan Chase & Co.: Weaknesses
JPMorgan Chase & Co.: Opportunities
JPMorgan Chase & Co.: Threats
JPMorgan Chase & Co.: Corporate Financial Deals Activity
JPMorgan Chase & Co.: Financial Deals Overview
JPMorgan Chase & Co.: Targets and Partners
JPMorgan Chase & Co.: Top Deals 2015 – 2019YTD*
JPMorgan Chase & Co.: Advisors
JPMorgan Chase & Co.: Top Legal Advisors
JPMorgan Chase & Co.: Top Financial Advisors
JPMorgan Chase & Co.: Mergers and Acquisitions
JPMorgan Chase & Co.: Corporate Venturing
JPMorgan Chase & Co.: Capital Raising
JPMorgan Chase & Co.: Divestments
JPMorgan Chase & Co.: Recent Developments
JPMorgan Chase & Co.: News and Events Summary
JPMorgan Chase & Co.: Business Expansion
JPMorgan Chase & Co.: Business Reorganization
JPMorgan Chase & Co.: Contracts
JPMorgan Chase & Co.: Financial Deals
JPMorgan Chase & Co.: IT Spending Announcements
JPMorgan Chase & Co.: Red Flags/DistressSignals
JPMorgan Chase & Co.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: JPMorgan Chase & Co.: Key Facts
Table 2: JPMorgan Chase & Co.: Key Employees
Table 3: JPMorgan Chase & Co.: Company History
Table 4: JPMorgan Chase & Co.: Locations and Subsidiaries
Table 5: JPMorgan Chase & Co.: Key Competitors
Table 6: JPMorgan Chase & Co.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: JPMorgan Chase & Co.: M&A Activity by Geography (TTM*)
Table 8: JPMorgan Chase & Co.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: JPMorgan Chase & Co.: M&A Average Deal Size - Value (US$m)
Table 10: JPMorgan Chase & Co.: Targets and Partners
Table 11: JPMorgan Chase & Co.: Top Deals 2015 - 2019YTD*
Table 12: JPMorgan Chase & Co.: Legal Advisor Ranking by Value (US$m)
Table 13: JPMorgan Chase & Co.: Financial Advisor Ranking by Value (US$m)
Table 14: JPMorgan Chase & Co.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: JPMorgan Chase & Co.: M&A Activity by Geography (2015 - YTD*2019)
Table 16: JPMorgan Chase & Co.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 17: JPMorgan Chase & Co.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 18: JPMorgan Chase & Co.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 19: JPMorgan Chase & Co.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 20: JPMorgan Chase & Co.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 21: JPMorgan Chase & Co.: Divestments by Geography (2015 - YTD*2019)
Table 22: JPMorgan Chase & Co.: News and Events Summary
Table 23: JPMorgan Chase & Co.: Business Expansion
Table 24: JPMorgan Chase & Co.: Business Reorganization
Table 25: JPMorgan Chase & Co.: Contracts
Table 26: JPMorgan Chase & Co.: Financial Deals
Table 27: JPMorgan Chase & Co.: IT Spending Announcements
Table 28: JPMorgan Chase & Co.: Red Flags/DistressSignals
Table 29: JPMorgan Chase & Co.: Strategy and Operations

List of Figures
Figure 1: JPMorgan Chase & Co.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: JPMorgan Chase & Co.: M&A Activity by Geography (TTM*)
Figure 3: JPMorgan Chase & Co.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 4: JPMorgan Chase & Co.: M&A Average Deal Size - Value (US$m)
Figure 5: JPMorgan Chase & Co.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 6: JPMorgan Chase & Co.: M&A Activity by Geography (2015 - YTD*2019)
Figure 7: JPMorgan Chase & Co.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 8: JPMorgan Chase & Co.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 9: JPMorgan Chase & Co.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 10: JPMorgan Chase & Co.: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 11: JPMorgan Chase & Co.: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 12: JPMorgan Chase & Co.: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[JPMorgan Chase & Co.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Colabor Group Inc (GCL)：企業の財務・戦略的SWOT分析
    Colabor Group Inc (GCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Viamet Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC, discovers and develops novel medicinal drugs based on metalloenzyme chemistry and biology technology platform. Its product pipeline includes clinical-stage compounds such as VT-1161, an oral inhibitor u …
  • The GPT Group：企業のM&A・事業提携・投資動向
    The GPT Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The GPT Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • LeMaitre Vascular Inc (LMAT)：医療機器：M&Aディール及び事業提携情報
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) provides medical devices and services for the treatment of peripheral vascular diseases. The company develops, manufactures, and markets disposable and implantable devices that vascular surgeons use in arteries and veins outside the heart in open vas …
  • BioLineRx Ltd (BLRX)：企業の財務・戦略的SWOT分析
    BioLineRx Ltd (BLRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Giner Inc：企業の製品パイプライン分析2018
    Summary Giner Inc (Giner) is a developer of proton exchange membranes and electrochemisty products. The company offers products such as electrolyzer stacks and systems. Its solutions include membrane characterization, dimensionally stable membrane, water quality sensors, trace gas sensors, ozone gen …
  • PetroChina Co Ltd (857)：石油・ガス：M&Aディール及び事業提携情報
    Summary PetroChina Co Ltd (PetroChina) operates a subsidiary of China National Petroleum Corporation. It is an oil and gas company that explores for and develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical pro …
  • Japan Airport Terminal Co Ltd：企業の戦略・SWOT・財務分析
    Japan Airport Terminal Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airport Terminal Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • KSK Group Berhad：企業の戦略・SWOT・財務情報
    KSK Group Berhad - Strategy, SWOT and Corporate Finance Report Summary KSK Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China CAMC Engineering Co Ltd (002051)：企業の財務・戦略的SWOT分析
    Summary China CAMC Engineering Co Ltd (CAMC), a subsidiary of China National Machinery Industry Corp, is a construction company that offers engineering, procurement and construction services. The company designs and constructs shipyard, turnkey project in pulp plant, agricultural equipment industria …
  • Intermountain Healthcare Inc-医療機器分野：企業M&A・提携分析
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • Midsona AB (MSON B)：企業の財務・戦略的SWOT分析
    Summary Midsona AB (Midsona), is a healthcare products manufacturing company that provides personal care products, health foods, and hygiene products. The company’s products include superfood, sports nutrition, dietary supplements, nutritional supplements, organic food, herbal teas, skin-care and be …
  • Applied Industrial Technologies Inc (AIT)：企業の財務・戦略的SWOT分析
    Applied Industrial Technologies Inc (AIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Protective Life Corporation：企業の戦略・SWOT・財務情報
    Protective Life Corporation - Strategy, SWOT and Corporate Finance Report Summary Protective Life Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Vaccinex Inc-製薬・医療分野：企業M&A・提携分析
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that focuses on the discovery and development of targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include SEMA4D, antibody platform and Act …
  • Spectrum Pharmaceuticals Inc (SPPI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection) …
  • Dr. Reddy’s Laboratories Ltd (DRREDDY)：企業の財務・戦略的SWOT分析
    Dr. Reddy's Laboratories Ltd (DRREDDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Citibank Berhad：企業の戦略的SWOT分析
    Citibank Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • TheraDiag SA (ALTER)：製薬・医療：M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • BioNTech AG：製薬・医療：M&Aディール及び事業提携情報
    Summary BioNTech AG (BioNTech) is a biopharmaceutical company that develops biomarker based diagnostics. The company’s products include RNXtract and mammatyper, and cell and gene therapies. It pipeline products include BioNTech mRNA pharmaceuticals, BioNTech cell and gene, BioNTech small molecules a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆